Melanotan I is sometimes discussed online in the context of skin pigmentation, but its regulatory and research status is often misunderstood. This overview sticks to what is verifiable about the compound itself.
Key takeaways
- Melanotan I has no FDA-approved label, brand name, or approved indication.
- It is classified here as an unapproved research compound.
- No clinical trials for melanotan i are currently registered.
- Its molecular formula is C78H111N21O19, with a molecular weight of about 1646.8 g/mol.
- Public chemical data for melanotan i is catalogued under PubChem CID 16197727.
What melanotan i is
Melanotan I is a synthetic peptide identified by the molecular formula C78H111N21O19 and a molecular weight near 1646.8 g/mol. It has not been evaluated or approved by any drug regulatory agency, and no official prescribing label exists for it. Because there is no approved label, there is no verified mechanism of action or drug classification to report here.
Trial footprint
There are no clinical trials for melanotan i currently registered in the reviewed database. This means there is no available count of studies, no phase information, and no trial status to summarize. Readers should not interpret the absence of trials as evidence of safety or effectiveness in either direction.